Gut microbiota in chronic obstructive pulmonary disease varies by CT-verified emphysema status
The gut microbiota in COPD differs from that in healthy individuals, even more so in emphysema. In particular, future studies should look into the mechanisms and therapeutic potential of dysbiosis affecting the family <i>Lachnospiraceae</i>.
Authors
- Kristoffer Ostridge (ORCID: https://orcid.org/0000-0001-8910-3900)
- Anders Ørskov Rotevatn (ORCID: https://orcid.org/0000-0001-6126-7591)
- Solveig Tangedal (ORCID: https://orcid.org/0000-0001-8060-5306)
- Tomas Eagan (ORCID: https://orcid.org/0000-0001-8725-9960)
- Gunnar Reksten Husebø (ORCID: https://orcid.org/0000-0001-6880-8215)
- Rune Nielsen
Institutions
- Haukeland University Hospital (NO)
- AstraZeneca (Brazil) (BR)
- AstraZeneca (Sweden) (SE)
- University of Southampton (GB)
- University of Bergen (NO)
Publication Details
- Journal
- European Clinical Respiratory Journal
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1080/20018525.2025.2470499
- Citations
- 2
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Helse Vest
- Medical Research Foundation